Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124983 | SCV000168423 | benign | not specified | 2013-10-16 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000124983 | SCV000311536 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Wong Mito Lab, |
RCV000714927 | SCV000845693 | benign | Combined oxidative phosphorylation defect type 14 | 2018-06-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000714927 | SCV001731157 | benign | Combined oxidative phosphorylation defect type 14 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000714927 | SCV001933312 | benign | Combined oxidative phosphorylation defect type 14 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001701760 | SCV001933313 | benign | Hereditary spastic paraplegia 77 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000124983 | SCV005091750 | benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 28% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 26. Only high quality variants are reported. |
Mayo Clinic Laboratories, |
RCV000677020 | SCV000802853 | benign | not provided | 2016-02-23 | no assertion criteria provided | clinical testing |